Machine-learning method aims to predict consequences of serious sleep disorder impacting millions in the U.S.
A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences (UAMS) research team led by Sue Griffin, Ph.D.
The society is concerned that new NIH subaward policy, if adopted, will harm the global scientific enterprise by disrupting collaboration and heighten administrative burden on scientists.
ASBMB emphasizes the importance of preserving research from scientists supported by the NIH, NSF and DOE during debt-ceiling deal
In testimony to federal appropriators, the ASBMB argues a big boost for NIGMS is long overdue and calls for a 10% increase
Cedars-Sinai has appointed Michael E. Farkouh, MD, MSc, as associate dean for Research and Clinical Trials and professor of Cardiology, effective March 1, 2023. A clinical cardiologist and epidemiologist, Farkouh is internationally known for his academic leadership and distinguished record of diabetes and cardiovascular disease clinical trials.
The Pulmonary Fibrosis Foundation has named Cedars-Sinai part of its Care Center Network, a group of medical centers that have demonstrated expertise in treating and supporting people with this deadly disease.
The new study showed apixaban is superior to rivaroxaban against stroke or systemic embolism in patients with atrial fibrillation and valvular heart disease
The Icahn School of Medicine at Mount Sinai has been awarded a five-year, $55.5 million grant from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) Program that will benefit the diverse patient population Mount Sinai serves by accelerating the development of new treatments for leading health conditions, including cardiorespiratory and psychiatric disorders, diabetes, malignancies, and infectious diseases.
The University of Illinois Chicago received $446 million in sponsored funding during the 2021 fiscal year, setting a record for research awards. The total amount represents an 8.6% increase over fiscal year 2020, with funding supporting over 3,500 research projects that move research to practical application.
Researchers recently created detailed simulations showing how stiff red blood cells flow through blood vessels, deforming and colliding along the way.
A website used by more than 20,000 scientists to analyze their genomic data is getting an upgrade, thanks to a four-year, nearly $870,000 National Institutes of Health grant.
In the earliest hours of your embryonic status, cells were developing and multiplying, critical processes were starting up, networks were connecting and genetic codes — for better or worse — were directing the whole project.
That early development is the focus of University of Delaware biologist Shuo Wei’s research. Now his work has won more than $1.8 million in support from the National Institutes of Health.
The Endocrine Society—the world’s largest professional organization for endocrine scientists and physicians—is calling on Congress to pass the House Labor-HHS spending bill to ensure health agencies are funded before the start of Fiscal Year 2021 and to avoid the tumult and disruption of a continuing resolution and potential government shutdowns.
First definitive molecular epidemiology study of SARS-CoV-2 in New York City to describe the route by which the virus arrived
With an estimated 1.7 million new cases and 600,000 deaths during 2017 in the U.S. alone, cancer remains a critical healthcare challenge. Researchers used the Comet supercomputer at the San Diego Supercomputer Center (SDSC) to evaluate their new molecular docking tool which aims to improve immunotherapy outcomes by identifying more effective personalized treatments.
While a huge focus is on health and mortality during the coronavirus outbreak, not to be forgotten are those who are grappling with death from natural causes, diseases, accidents and crime. Funerals and visitations are the customary means of support friends and loved ones — but restricted travel and social distancing poses challenges.
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C. Importantly, the legislation also brings essential resources to combat antibiotic resistance, find and develop new infection fighting drugs and bring them to market. The balanced approach of this legislation will serve patients and public health.